iSpecimen Inc. (ISPC) stock

ISPCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 7/3032% below fair value

$0.66−0.04 (-5.43%)

Close on Nov 13, 2026Market cap $1.66MP/E –Yield –

iSpecimen operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

iSpecimen's operating income for the twelve months ending Jun 30, 2026 was -$9.42M. For fiscal 2025 it was -$8.98M. The highest annual figure on record is -$2.41M in fiscal 2020.

Annual operating income

Period	Period end	Value	Change
FY2025	Dec 31, 2025	-$8.98M	–
FY2024	Dec 31, 2024	-$12.73M	–
FY2023	Dec 31, 2023	-$11.17M	–
FY2022	Dec 31, 2022	-$10.19M	–
FY2021	Dec 31, 2021	-$5.93M	–
FY2020	Dec 31, 2020	-$2.41M	–

Quarterly operating income

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q2 FY2026	Jun 30, 2026	-$1.36M	–
Q1 FY2026	Mar 31, 2026	-$2.54M	–
Q4 FY2025	Dec 31, 2025	-$2.69M	–
Q3 FY2025	Sep 30, 2025	-$2.83M	–
Q2 FY2025	Jun 30, 2025	-$1.82M	–
Q1 FY2025	Mar 31, 2025	-$1.64M	–
Q4 FY2024	Dec 31, 2024	-$5.84M	–
Q3 FY2024	Sep 30, 2024	-$1.71M	–
Q2 FY2024	Jun 30, 2024	-$2.18M	–
Q1 FY2024	Mar 31, 2024	-$3.00M	–
Q4 FY2023	Dec 31, 2023	-$2.87M	–
Q3 FY2023	Sep 30, 2023	-$2.19M	–
Q2 FY2023	Jun 30, 2023	-$3.56M	–
Q1 FY2023	Mar 31, 2023	-$2.54M	–
Q4 FY2022	Dec 31, 2022	-$2.14M	–
Q3 FY2022	Sep 30, 2022	-$3.10M	–
Q2 FY2022	Jun 30, 2022	-$2.59M	–
Q1 FY2022	Mar 31, 2022	-$2.36M	–
Q4 FY2021	Dec 31, 2021	-$1.99M	–
Q3 FY2021	Sep 30, 2021	-$1.46M	–
Q2 FY2021	Jun 30, 2021	-$1.53M	–
Q1 FY2021	Mar 31, 2021	-$942.64K	–
Q4 FY2020	Dec 31, 2020	-$934.45K	–
Q3 FY2020	Sep 30, 2020	-$723.08K	–
Q2 FY2020	Jun 30, 2020	-$305.01K	–